Author name: Yali Friedman

Suit targets 13 generic drug makers “Jumping into the escalating legal battle against pharmaceutical manufacturers, Attorney General Thomas F. Reilly […]

Judge Allows Antitrust Case Against Seed Producers “A federal judge on Friday let proceed an antitrust case that accused the

Definitions Impede Stem-Cell Work The medical promise of embryonic stem-cell research has been plagued by ethical controversy. Now, an apparent

Bioterror Brain Drain “Infectious-disease specialists are following the big bucks to Washington’s new multibillion-dollar program on bioterrorism research�but at what

A dose of reality “The FDA yesterday opened two days of hearings on the subject of consumer advertising, for the

Naturally blonde, brunette… “Designer ‘therapies’ could one day be helping to restore our hair to its former colour and texture”

Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome “Just before lunch today at the GSAC conference, Craig Venter

The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development While almost everyone in the drug industry is

GlaxoSmithKline Reveals Ingenuity In a further validation of Big Pharma�s acceptance of systems biology, GlaxoSmithKline has licensed part of the

The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including